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2009-2010 Influenza Season 
Week 41 ending October 17, 2009 
All data are preliminary and may change as more reports are received. 
 
Synopsis: During week 41 (October 11-17, 2009), influenza activity increased in the U.S. 
o 4,855 (37.5%) specimens tested by U.S. World Health Organization (WHO) and National 
Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and 
reported to CDC/Influenza Division were positive for influenza. 
o All subtyped influenza A viruses being reported to CDC were 2009 influenza A (H1N1) 
viruses. 
o The proportion of deaths attributed to pneumonia and influenza (P&I) was above the 
epidemic threshold.  
o Eleven influenza-associated pediatric deaths were reported. Nine of these deaths were 
associated with 2009 influenza A (H1N1) virus infection and two were associated with an 
influenza A virus for which subtype is undetermined. 
o The proportion of outpatient visits for influenza-like illness (ILI) was above the national 
baseline. All 10 regions reported ILI above region-specific baseline levels. 
o Forty-six states reported geographically widespread influenza activity, Guam and three 
states reported regional influenza activity, one state, the District of Columbia, and Puerto 
Rico reported local influenza activity, and the U.S. Virgin Islands did not report. 
 
National and Regional Summary of Select Surveillance Components 
 Data for current week Data cumulative since August 30, 2009 (Week 35)* 
HHS 
Surveillance 
Regions** 
Out-
patient 
ILI† 
% 
positive 
for flu‡ 
Number of  
jurisdictions 
reporting 
regional or 
widespread 
activity§  
A (H1) A (H3) 2009 A (H1N1) 
A  
(unable 
to sub-
type)¥ 
A 
(Subty-
ping not 
perfor-
med) 
B  Pediatric Deaths 
Nation Elevated 37.5% 50 of 54 15 34 17,108 270 10,025 68 53 
Region 1 Elevated 9.0% 6 of 6 5 2 268 2 27 3 0 
Region 2 Elevated 6.1% 2 of 4 1 5 91 0 72 2 0 
Region 3 Elevated 49.4% 5 of 6 1 5 2,694 11 313 6 4 
Region 4 Elevated 28.9% 8 of 8 0 1 2,537 48 2,830 8 16 
Region 5 Elevated 37.3% 6 of 6 3 14 2,618 69 399 6 3 
Region 6 Elevated 20.5% 5 of 5 0 3 1,495 3 2,932 5 19 
Region 7 Elevated 45.4% 4 of 4 3 2 1,641 122 501 10 1 
Region 8 Elevated 32.4% 6 of 6 2 0 2,547 0 2,525 24 5 
Region 9 Elevated 24.3% 4 of 5 0 1 2,163 11 351 3 2 
Region 10 Elevated 36.8% 4 of 4 0 1 1,054 4 75 1 3 
*Influenza season officially begins each year at week 40. This season data from week 35 will be included to show the trend of influenza activity before the official start of the 
2009-10 influenza season. 
**HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, US Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, 
SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; 
and Region 10: AK, ID, OR, WA). 
† Elevated means the % of visits for ILI is at or above the national or region-specific baseline. 
‡ National data are for current week; regional data are for the most recent three weeks. 
§ Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and U.S. Virgin Islands. 
¥ The majority of influenza A viruses that cannot be sub-typed as seasonal influenza viruses are 2009 A (H1N1) influenza viruses upon further testing. 
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U.S. Virologic Surveillance:  WHO and NREVSS collaborating laboratories located in all 50 states 
and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and 
the number positive by influenza type and subtype. The results of tests performed during the 
current week are summarized in the table below. 
 
 
 Week 41 
No. of specimens tested 12,943 
No. of positive specimens (%) 4,855 (37.5%) 
Positive specimens by type/subtype  
Influenza A 4,844 (99.8%) 
          A (2009 H1N1)   3,378 (69.7%)  
          A (subtyping not performed)          1,436 (29.6%)
          A (unable to subtype)  30 (0.6%)  
          A (H3)                0 (0.0%)  
          A (H1) 0 (0.0%)
Influenza B 11 (0.2%) 
 
During week 41, influenza B viruses co-circulated at low levels with 2009 influenza A (H1N1) 
viruses.  All subtyped influenza A viruses reported to CDC this week were 2009 influenza A (H1N1) 
viruses. 
Influenza Positive Tests Reported to CDC by U.S. WHO/NREVSS 
Collaborating Laboratories, National Summary, August 30-October 17, 2009 
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Pneumonia and Influenza Hospitalization and Death Tracking: This new system was 
implemented on August 30, 2009, and replaces the weekly report of laboratory confirmed 2009 
H1N1-related hospitalizations and deaths that began in April 2009.  Jurisdictions can now report to 
CDC either laboratory confirmed or pneumonia and influenza syndromic-based counts of 
hospitalizations and deaths resulting from all types or subtypes of influenza, not just those from 
2009 H1N1 influenza virus.  To allow jurisdictions to implement the new case definition, counts 
were reset to zero on August 30, 2009.  From August 30 – October 17, 2009, 8,204 laboratory-
confirmed influenza associated hospitalizations, 411 laboratory-confirmed influenza associated 
deaths, 21,823 pneumonia and influenza syndrome-based hospitalizations, and 2,416 pneumonia 
and influenza syndrome-based deaths, were reported to CDC. CDC will continue to use its 
traditional surveillance systems to track the progress of the 2009-10 influenza season.   
Weekly Laboratory-Confirmed Influenza-Associated Hospitalizations and 
Deaths, National Summary, August 30 – October 17, 2009 
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Antigenic Characterization:  CDC has antigenically characterized 137 2009 influenza A (H1N1) 
viruses collected since September 1, 2009.  No seasonal A(H1N1), A(H3N2) or B viruses 
collected during this period were available for testing.  
All 137 2009 A (H1N1) viruses are related to the A/California/07/2009 (H1N1) reference virus 
selected by WHO as the 2009 H1N1 vaccine virus.   
Annual influenza vaccination is expected to provide the best protection against those virus 
strains that are related to the vaccine strains, but limited to no protection may be expected when the 
vaccine and circulating virus strains are so different as to be from different lineages.  Antigenic 
characterization of 2009 influenza A (H1N1) viruses indicates that these viruses are only distantly 
related antigenically and genetically to seasonal influenza A (H1N1) viruses, suggesting that little to 
no protection would be expected from vaccination with seasonal influenza vaccine. 
Antiviral Resistance: Since September 1, 2009, 114 2009 influenza A (H1N1) virus isolates have 
been tested for resistance to the neuraminidase inhibitors (oseltamivir and zanamivir).  In addition, 
466 2009 influenza A (H1N1) original clinical samples were tested for a single known mutation in 
the virus that confers oseltamivir resistance.  Because of the low level of circulation of seasonal 
influenza A (H1N1), A (H3N2), and influenza B viruses, no samples collected since September 1, 
2009 were available for antiviral resistance testing.  Additional laboratories perform antiviral testing 
and report their results to CDC.  The results of antiviral resistance testing performed on these 
viruses are summarized in the table below.     
Antiviral Resistance Testing Results on Samples Collected Since September 1, 2009. 
Resistant 
Viruses, 
Number (%) 
Resistant 
Viruses, 
Number (%)  Viruses tested (n) 
Oseltamivir 
Viruses 
tested (n) 
Zanamivir 
Seasonal 
Influenza A 
(H1N1) 
0 0 (0) 0 0 (0) 
Influenza A 
(H3N2) 0 0 (0) 0 0 (0) 
Influenza B 0 0 (0) 0 0 (0) 
2009 
Influenza A  
(H1N1) 
580 3†‡ (0.5) 114 0 (0) 
†Two screening tools were used to determine oseltamivir resistance: sequence analysis of viral genes and a neuraminidase inhibition 
assay. 
‡ Additional laboratories perform antiviral resistance testing and report their results to CDC.  Two additional oseltamivir resistant 2009 
influenza A (H1N1) viruses have been identified by these laboratories since September 1, 2009, bringing the total number to 5. 
 
All of the subtyped influenza A viruses reported during week 41 were 2009 influenza A (H1N1) 
viruses, and 100% of all 2009 H1N1 viruses tested since the virus emerged in April 2009 have been 
resistant to the adamantanes (amantadine and rimantadine).  Currently, adamantane antiviral 
susceptibility testing has been suspended to allow a focus on neuraminidase inhibitors.   
 
Antiviral treatment with oseltamivir or zanamivir is recommended for all patients with confirmed or 
suspected influenza virus infection who are hospitalized or who are at higher risk for influenza 
complications.  Additional information on antiviral recommendations for treatment and 
chemoprophylaxis of influenza virus infection is available at 
http://www.cdc.gov/H1N1flu/recommendations.htm.   
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2009 influenza A (H1N1) viruses were tested for oseltamivir resistance by a neuraminidase 
inhibition assay and/or detection of genetic sequence mutation, depending on the type of specimen 
tested.  Original clinical samples were examined for a single known mutation in the virus that 
confers oseltamivir resistance in currently circulating seasonal influenza A (H1N1) viruses, while 
influenza virus isolates were tested using a neuraminidase inhibition assay that determines the 
presence or absence of neuraminidase inhibitor resistance, followed by the neuraminidase gene 
sequence analysis of resistant viruses.   
 
The majority of 2009 influenza A (H1N1) viruses are susceptible to the neuraminidase inhibitor 
antiviral medication oseltamivir; however, rare sporadic cases of oseltamivir resistant 2009 
influenza A (H1N1) viruses have been detected worldwide.  Since September 1, 2009, five cases 
have been identified in the United States, and a total of 14 cases of oseltamivir resistant 2009 
influenza A (H1N1) viruses have been identified in the United States since April 2009 (11 viruses 
identified by CDC and three viruses identified by additional laboratories).  The 14 total cases 
represent an increase of one case over the previous week.  All tested viruses retain their sensitivity 
to the neuraminidase inhibitor zanamivir.  Twelve patients (including 10 of the viruses detected at 
CDC and two viruses identified by the additional laboratories) had documented exposure to 
oseltamivir through either treatment or chemoprophylaxis, one patient is under investigation to 
determine exposure to oseltamivir, and one patient had no documented oseltamivir exposure.  
Occasional development of oseltamivir resistance during treatment or prophylaxis is not 
unexpected.  Enhanced surveillance is expected to detect additional cases of oseltamivir resistant 
2009 influenza A (H1N1) viruses, and such cases will be investigated to assess the spread of 
resistant strains in the community.   
 
To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of 
the need to continue hand and cough hygiene measures for the duration of any symptoms of 
influenza, even while taking antiviral medications 
(http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5832a3.htm).  
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Pneumonia and Influenza (P&I) Mortality Surveillance:  During week 41, 6.9% of all deaths 
reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was 
above the epidemic threshold of 6.6% for week 41. Including week 41, P&I mortality has been 
above threshold for three consecutive weeks. 
 
Pneumonia and Influenza Mortality for 122 U.S. Cities 
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Influenza-Associated Pediatric Mortality:  Eleven influenza-associated pediatric deaths were 
reported to CDC during week 41 (Georgia [2], Hawaii, Louisiana, Oklahoma [2], Ohio, North 
Carolina, Oregon, Texas, and Virginia).  Nine of these deaths were associated with 2009 influenza 
A (H1N1) virus infection and two were associated with an influenza A virus for which the subtype is 
undetermined.  These deaths occurred between June 14 and October 10, 2009.  One death 
reported during week 41 occurred during the 2008-09 season.  Since August 30, 2009, CDC has 
received 53 reports of influenza-associated pediatric deaths that occurred during the current 
influenza season (three deaths in children less than 2 years, seven deaths in children 2-4 years, 21 
deaths in children 5-11 years, and 22 deaths in individuals 12-17 years). Forty-seven of the 53 
deaths were due to 2009 influenza A (H1N1) virus infections, and the remaining six were 
associated with influenza A virus for which the subtype is undetermined.  A total of 95 deaths in 
children associated with 2009 H1N1 virus have been reported to CDC. 
 
Among the 53 deaths in children, 32 children had specimens collected for bacterial culture from 
normally sterile sites and seven (21.9%) of the 32 were positive; Staphylococcus aureus was 
identified in five (71.4%) of the seven children.  One S. aureus isolate was sensitive to methicillin, 
three were methicillin resistant, and one did not have sensitivity testing performed.  All seven 
children with bacterial coinfections were five years of age or older and four (57.1%) of the seven 
children were 12 years of age or older. 
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Number of Influenza-Associated Pediatric Deaths by Week of Death: 
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Number of Deaths 
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Influenza-Associated Hospitalizations:  Laboratory-confirmed influenza-associated 
hospitalizations are monitored using a population-based surveillance network that includes the 10 
Emerging Infections Program (EIP) sites (CA, CO, CT, GA, MD, MN, NM, NY, OR and TN) and 6 
new sites (IA, ID, MI, ND, OK and SD). 
During September 1, 2009 – October 17, 2009, the following preliminary laboratory-confirmed 
overall influenza associated hospitalization rates were reported by EIP and the new sites (rates 
include influenza A, influenza B, and 2009 influenza A (H1N1)): 
Rates [EIP (new sites)] for children aged 0-4 years and 5-17 years were 1.9 (3.0) and 0.9 (1.6) per 
10,000, respectively. Rates [EIP (new sites)] for adults aged 18-49 years, 50-64 years, and ≥ 65 
years were 0.6 (0.6), 0.6 (0.6) and 0.5 (0.4) per 10,000, respectively. 
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EIP Influenza Laboratory-Confirmed Cumulative Hospitalization Rates, 
2009-10 and Previous Three Seasons* 
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*2006-07 & 2007-08 (Oct 1–Apr 30); 2008-09 (Oct 1–Apr 14, limited due to emergence of 2009 H1N1). 
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Outpatient Illness Surveillance: Nationwide during week 41, 7.1% of patient visits reported 
through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to 
influenza-like illness (ILI).  This percentage is above the national baseline of 2.3%. 
 
Percentage of Visits for Influenza-like Illness (ILI) Reported by  
the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), 
Weekly National Summary, October 1, 2006 - October 17, 2009 
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On a regional level, the percentage of outpatient visits for ILI ranged from 2.7% to 12.5% during 
week 41, and increased in eight of the 10 surveillance regions compared to the previous week. All 
10 regions reported a proportion of outpatient visits for ILI above their region-specific baseline 
levels.   
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Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists:  The 
influenza activity reported by state and territorial epidemiologists indicates geographic spread of 
both seasonal influenza and 2009 influenza A (H1N1) viruses and does not measure the severity of 
influenza activity. 
 
During week 41, the following influenza activity was reported: 
 Widespread influenza activity was reported by 46 states (Alabama, Alaska, Arizona, 
Arkansas, California, Colorado, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, 
Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, 
Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New 
York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, 
South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, 
Wisconsin, and Wyoming). 
 Regional influenza activity was reported by Guam and three states (Connecticut, New 
Jersey, and South Carolina). 
 Local influenza activity was reported by the District of Columbia, Puerto Rico, and one state 
(Hawaii). 
 The U.S. Virgin Islands did not report. 
A description of surveillance methods is available at: http://www.cdc.gov/flu/weekly/fluactivity.htm 
 
Report prepared: October 23, 2009. 
 
